A β-Amyloid(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer’s Disease

A β-Amyloid(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer’s Disease

Background: Alzheimer’s disease (AD) is a common form of dementia, characterized by production and deposition of β-amyloid peptide in the brain. Thus, β-amyloid peptide is a potentially promising biomarker used to diagnose and monitor the progression of AD. Objective: The study aims to develop a bio...

Full description

Bibliographic Details
Main Authors:	Rezvan Dehdari Vais, Hossein Yadegari, Hossein Heli, Naghmeh Sattarahmady
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2021-04-01
Series:	Journal of Biomedical Physics and Engineering
Subjects:	beta-amyloid β-amyloid (1-40) molecular imprinting artificial antibody neurodegenerative disease sensory aids biosensing technique bioprobe
Online Access:	https://jbpe.sums.ac.ir/article_47375_d78e362360728230db4ad66839e0c3f7.pdf

Similar Items

Molecularly Imprinted Polymer-Amyloid Fibril-Based Electrochemical Biosensor for Ultrasensitive Detection of Tryptophan
by: Ibrar Alam, et al.
Published: (2022-05-01)

Novel, Inexpensive, and Scalable Amyloid Fibril Formation Method
by: Ethan Hessick, et al.
Published: (2022-02-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Advances in Molecularly Imprinting Technology for Bioanalytical Applications
by: Runfa Li, et al.
Published: (2019-01-01)

Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease
by: Abhinav Sharma, et al.
Published: (2023-07-01)

Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy
by: Sigal Rencus-Lazar, et al.
Published: (2019-03-01)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
by: Michelle R. Campbell, et al.
Published: (2021-01-01)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
by: Neville Vassallo, et al.
Published: (2023-06-01)

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
by: Nima Sasanian, et al.
Published: (2020-06-01)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury
by: Iftakher Hossain, et al.
Published: (2020-05-01)

Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer’s Disease
by: Coad Thomas Dow, et al.
Published: (2022-02-01)

Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status
by: Shogyoku Bun, et al.
Published: (2023-09-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Quantitative tracing of bioprobes by simultaneously monitoring radiative and nonradiative relaxations
by: Hongjiang Chen, et al.
Published: (2023-07-01)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
by: Julia Ring, et al.
Published: (2022-05-01)

Gold nanoparticles from magnetite for the detection of amyloid proteins in neurodegenerative diseases
by: Alejandro ORTIZ, et al.
Published: (2022-01-01)

Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications
by: Ki Sung Park, et al.
Published: (2024-03-01)

Amyloid proteins : methods and protocols /
by: Sigurdsson, Einar M.
Published: (2005)

Amyloid Precursor Protein and Alzheimer’s Disease
by: Kseniia S. Orobets, et al.
Published: (2023-09-01)

Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism
by: Jiaying Hu, et al.
Published: (2023-10-01)

Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein
by: Maria Medvedeva, et al.
Published: (2022-09-01)

Lysosomal dysfunction induced cytosolic vacuolation and increased intracellular amyloid-beta 42 (Aβ42) in human brain endothelial cells (HBEC-5i)
by: Iffah Nadiah Laili, et al.
Published: (2023-05-01)

Matriptase cleaves the amyloid-beta peptide 1–42 at Arg-5, Lys-16, and Lys-28
by: Li-Mei Chen, et al.
Published: (2019-01-01)

Recent High-Resolution Structures of Amyloids Involved in Neurodegenerative Diseases
by: Rodrigo Diaz-Espinoza
Published: (2021-11-01)

Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia
by: Lise Colmant, et al.
Published: (2024-01-01)

Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation
by: Peter K. Windsor, et al.
Published: (2021-03-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01)

Molecular Imprinting Techniques Used for the Preparation of Biosensors
by: Gizem Ertürk, et al.
Published: (2017-02-01)

Molecular Imprinting on Nanozymes for Sensing Applications
by: Ana R. Cardoso, et al.
Published: (2021-05-01)

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
by: Gabriela Dumitrita Stanciu, et al.
Published: (2020-06-01)

Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
by: Daniel J. Figdore, et al.
Published: (2024-01-01)

Potentiometric Biosensor Based on Artificial Antibodies for an Alzheimer Biomarker Detection
by: Sónia Claúdia Ribeiro, et al.
Published: (2022-04-01)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
by: Ling-Yun Fan, et al.
Published: (2018-06-01)

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
by: Inge M. W. Verberk, et al.
Published: (2020-09-01)

Amyloid and amyloidosis /
by: Skinner, Martha, et al.
Published: (2005)

Analysis of Amyloid-β Pathology Spread in Mouse Models Suggests Spread Is Driven by Spatial Proximity, Not Connectivity
by: Chris Mezias, et al.
Published: (2017-12-01)

Biosensors and Molecular Imprinting /
by: Mattiasson, Bo, editor 634887, et al.
Published: (2017)

Cerebral amyloid angiopathy-related inflammation (CAARI): case report
by: Karol Adam Makarewicz, et al.
Published: (2019-06-01)

Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A
by: Xuguang Lin, et al.
Published: (2021-01-01)